The Legionella Testing Market Size is valued at USD 295.21 Mn in 2022 and is predicted to reach USD 551.37 Mn by the year 2031 at a 7.3% CAGR during the forecast period for 2023-2031.
Legionella testing detects the presence of the bacterium Legionella pneumophila and other related species in water sources. The testing procedure is critical for identifying potential Legionella contamination sources and averting Legionnaires' disease outbreaks. Legionella testing procedures have become more efficient and accurate as testing technology has advanced.
PCR-based testing and next-generation sequencing (NGS) are two technologies that have gained popularity as a result of their shorter turnaround times and ability to deliver more detailed information. The technologies that power molecular diagnostics are fast improving to aid in the fight against rapidly spreading infectious disease pandemics. The traditional Legionella testing method based on microbial culture technology is time-consuming and labor-intensive.
However, certain industries, such as hospitality and tourism, were significantly affected by the pandemic, leading to reduced occupancy or temporary closures of hotels, resorts, and other facilities. These changes could have influenced the demand for Legionella testing in these sectors.
The Legionella Testing Market is segmented on the basis of test type and end-use. Acording to test type, the market is segmented as culture, Urine Antigen Test (UAT), and Direct Fluorescent Antibody (DFA) Test. The end-user segment includes hospitals & clinics, diagnostics laboratories, and water treatment industries.
The Urine Antigen Test (UAT) category is expected to hold a major share of the global Legionella Testing Market in 2022. This is the most widely used laboratory test for detecting legionella bacteria in urine. It can offer results on the same day as the sample collection, as opposed to culture media approaches, which take 7 to 8 days. Furthermore, it is a low-cost test that is more popular among people from underdeveloped or developing countries. Rapidly rising PCR technology to dominate the market with a higher CAGR over the forecast period due to the maximum selectivity and specificity of the test.
The diagnostics laboratories segment is projected to grow at a rapid rate in the global Legionella Testing Market. This is due to the increasing prevalence of Legionnaire disease, more awareness, and increased penetration of improved assays for Legionella infection detection. This dominance is expected to persist throughout the projection period. The other segment, which encompasses environmental testing in addition to clinical Legionella bacteria testing, is expected to grow rapidly due to the advent of onsite testing methodologies and the enforcement of rigorous rules for routine water check-ups.
The North America Legionella Testing Market is expected to register the topmost market share in terms of revenue in the near future. The market in this region is distinguished by high Legionnaire disease diagnostic rates, the presence of world-class healthcare infrastructure, high illness awareness, and severe water testing requirements.
The presence of a large geriatric population that is readily infected, together with the high risk of mortality owing to associated pneumonia among such patients, prioritizes Legionella testing in countries such as the United States, which is adding momentum to the regional market. The Asia-Pacific market is expected to grow at a substantial CAGR within the forecast period due to economic development, an empowered healthcare industry, and increased awareness of available test products in the region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 295.21 Mn |
|
Revenue Forecast In 2031 |
USD 551.37 Mn |
|
Growth Rate CAGR |
CAGR of 7.3 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Test Type, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Biomérieux, Merck KGaA, Quidel Corporation, Abbott Laboratories, Aquacert Ltd, Phigenics, LLC, Pall Corporation, and Evoqua Water Technologies LLC |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Legionella Testing Market Snapshot
Chapter 4. Global Legionella Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: Test Type Estimates & Trend Analysis
5.1. Test Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following Test Type:
5.2.1. Culture
5.2.2. Urine Antigen Test (UAT)
5.2.3. Direct Fluorescent Antibody (DFA) Test
5.2.4. Polymerase Chain Reaction (PCR)
5.2.5. Others
Chapter 6. Market Segmentation 2: By End Use Estimates & Trend Analysis
6.1. Test Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End Use:
6.2.1. Hospitals and clinics
6.2.2. Diagnostic Laboratories
6.2.3. Water Treatment Industries
Chapter 7. Legionella Testing Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Legionella Testing Market revenue (US$ Million) estimates and forecasts Test Type, 2023-2031
7.1.2. North America Legionella Testing Market revenue (US$ Million) estimates and forecasts By End Use, 2023-2031
7.1.3. North America Legionella Testing Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Legionella Testing Market revenue (US$ Million) Test Type, 2023-2031
7.2.2. Europe Legionella Testing Market revenue (US$ Million) By End Use, 2023-2031
7.2.3. Europe Legionella Testing Market revenue (US$ Million) by country, 2023-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Legionella Testing Market revenue (US$ Million) Test Type, 2023-2031
7.3.2. Asia Pacific Legionella Testing Market revenue (US$ Million) By End Use, 2023-2031
7.3.3. Asia Pacific Legionella Testing Market revenue (US$ Million) by country, 2023-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Legionella Testing Market revenue (US$ Million) Test Type, 2023-2031
7.4.2. Latin America Legionella Testing Market revenue (US$ Million) By End Use, 2023-2031
7.4.3. Latin America Legionella Testing Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Legionella Testing Market revenue (US$ Million) Test Type, (US$ Million)
7.5.2. Middle East & Africa Legionella Testing Market revenue (US$ Million) By End Use, (US$ Million)
7.5.3. Middle East & Africa Legionella Testing Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
9.2.1. Thermo Fisher Scienific, Inc. (US)
9.2.2. Merck KGaA (Germany)
9.2.3. Becton, Dickinson, and Company (US)
9.2.4. Roche Diagnostics (Switzerland)
9.2.5. Pall Corporation (US)
9.2.6. Pro-lab Diagnostics Inc.
9.2.7. Beckman Coulter Inc.
9.2.8. Bio-Rad Laboratories Inc.
9.2.9. Alere Inc. (Abbott Rapid Diagnostics)
9.2.10. Eiken Chemical Co. Ltd.
9.2.11. Hologic Inc.
9.2.12. QIAGEN
9.2.13. Takara Bio Inc.
9.2.14. Environmental Safety Technologies Inc.
9.2.15. Hydrosense
9.2.16. Accepta Ltd.
9.2.17. LuminUltra Technologies Ltd.
9.2.18. Pro-Lab Diagnostics Inc.
9.2.19. BioAlert Solutions
9.2.20. Pacific Water Technology
9.2.21. Aquacert Ltd.
9.2.22. DTK Water
9.2.23. Sens Solutions
9.2.24. Genomadix Inc.
9.2.25. Phigenics LLC
9.2.26. Other Prominent Players
Legionella Testing Market By Test Type-
Legionella Testing Market By End-Use-
Legionella Testing Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
